Terms: = Liver cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71
56 results:
1. E3 ubiquitin ligase CHIP interacts with transferrin receptor 1 for degradation and promotes cell proliferation through inhibiting ferroptosis in hepatocellular carcinoma.
Shao M; Qi K; Wang L; Yu X; Zhang Q; Yu L; Wang L; Yang C; Fan L
Cell Signal; 2024 Jun; 118():111148. PubMed ID: 38521179
[TBL] [Abstract] [Full Text] [Related]
2. Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway.
Wang F; Xu WQ; Zhang WQ; Xu RC; Sun JL; Zhang GC; Liu ZY; Qi ZR; Dong L; Weng SQ; Shen XZ; Liu TT; Fang Y; Zhu JM
Hepatol Int; 2024 Apr; 18(2):636-650. PubMed ID: 37982952
[TBL] [Abstract] [Full Text] [Related]
3. Tracking the binding site of anticancer drug fluxoridin with Fe-related proteins to achieve intelligent drug delivery.
Shahraki S; Delarami HS; Razmara Z; Heidari A
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Feb; 306():123569. PubMed ID: 37925954
[TBL] [Abstract] [Full Text] [Related]
4. Differences in hepatocellular iron metabolism underlie sexual dimorphism in hepatocyte ferroptosis.
Tao H; Dar HY; Tian C; Banerjee S; Glazer ES; Srinivasan S; Zhu L; Pacifici R; He P
Redox Biol; 2023 Nov; 67():102892. PubMed ID: 37741044
[TBL] [Abstract] [Full Text] [Related]
5. Transferrin Receptor is Associated with Sensitivity to Ferroptosis Inducers in Hepatocellular Carcinoma.
Hiromatsu M; Toshida K; Itoh S; Harada N; Kohashi K; Oda Y; Yoshizumi T
Ann Surg Oncol; 2023 Dec; 30(13):8675-8689. PubMed ID: 37548836
[TBL] [Abstract] [Full Text] [Related]
6. Artemisia argyi H.Lév. & Vaniot essential oil induces ferroptosis in pancreatic cancer cells via up-regulation of tfr1 and depletion of γ-glutamyl cycle.
Zhang N; Zhang J; Cui W; Wu D; Zhang J; Wei B; Qu L; Xu X
Fitoterapia; 2023 Jul; 168():105522. PubMed ID: 37169131
[TBL] [Abstract] [Full Text] [Related]
7. The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
Kameda K; Yanagiya R; Miyatake Y; Carreras J; Higuchi H; Murayama H; Ishida T; Ito A; Iida S; Fukuhara N; Harigae H; Fujioka Y; Takahashi N; Wada H; Ishida F; Nakazawa H; Ishihara R; Murakami Y; Tagawa H; Matsuura T; Nakagawa S; Iwabuchi S; Hashimoto S; Imadome KI; Nakamura N; Ishizawa K; Kanda Y; Ando K; Kotani A
Blood; 2023 Jul; 142(4):352-364. PubMed ID: 37146246
[TBL] [Abstract] [Full Text] [Related]
8. KLF14 regulates the growth of hepatocellular carcinoma cells via its modulation of iron homeostasis through the repression of iron-responsive element-binding protein 2.
Zhou H; Chen J; Fan M; Cai H; Dong Y; Qiu Y; Zhuang Q; Lei Z; Li M; Ding X; Yan P; Lin A; Zheng S; Yan Q
J Exp Clin Cancer Res; 2023 Jan; 42(1):5. PubMed ID: 36600258
[TBL] [Abstract] [Full Text] [Related]
9. Loss of SLC46A1 decreases tumor iron content in hepatocellular carcinoma.
Wang D; Wu H; Yang J; Li M; Ling C; Gao Z; Lu H; Shen H; Tang Y
Hepatol Commun; 2022 Oct; 6(10):2914-2924. PubMed ID: 35811443
[TBL] [Abstract] [Full Text] [Related]
10. Re-engineering the inner surface of ferritin nanocage enables dual drug payloads for synergistic tumor therapy.
Wang Z; Zhao Y; Zhang S; Chen X; Sun G; Zhang B; Jiang B; Yang Y; Yan X; Fan K
Theranostics; 2022; 12(4):1800-1815. PubMed ID: 35198074
[No Abstract] [Full Text] [Related]
11. Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages.
Sun JL; Zhang NP; Xu RC; Zhang GC; Liu ZY; Abuduwaili W; Wang F; Yu XN; Shi X; Song GQ; Wu H; Liu TT; Shen XZ; Deng B; Weng SQ; Dong L; Zhu JM
J Transl Med; 2021 Aug; 19(1):347. PubMed ID: 34389031
[TBL] [Abstract] [Full Text] [Related]
12. Identification of Key Genes for Hepatitis Delta Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhang C; Wu S; Yang XD; Xu H; Ma T; Zhu QX
Turk J Gastroenterol; 2021 Feb; 32(2):169-177. PubMed ID: 33960941
[TBL] [Abstract] [Full Text] [Related]
13. On Iron Metabolism and Its Regulation.
Vogt AS; Arsiwala T; Mohsen M; Vogel M; Manolova V; Bachmann MF
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925597
[TBL] [Abstract] [Full Text] [Related]
14. Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity.
Hou Y; Liang HL; Yu X; Liu Z; Cao X; Rao E; Huang X; Wang L; Li L; Bugno J; Fu Y; Chmura SJ; Wu W; Luo SZ; Zheng W; Arina A; Jutzy J; McCall AR; Vokes EE; Pitroda SP; Fu YX; Weichselbaum RR
Sci Transl Med; 2021 Feb; 13(582):. PubMed ID: 33627484
[TBL] [Abstract] [Full Text] [Related]
15. High activity and low toxicity of a novel cd71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors.
Falvo E; Damiani V; Conti G; Boschi F; Messana K; Giacomini P; Milella M; De Laurenzi V; Morea V; Sala G; Fracasso G; Ceci P
J Exp Clin Cancer Res; 2021 Feb; 40(1):63. PubMed ID: 33568214
[TBL] [Abstract] [Full Text] [Related]
16. Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation.
Xiao C; Fu X; Wang Y; Liu H; Jiang Y; Zhao Z; You F
PLoS One; 2020; 15(12):e0243812. PubMed ID: 33351833
[TBL] [Abstract] [Full Text] [Related]
17. Intratumoral CD45
Chen J; Qiao YD; Li X; Xu JL; Ye QJ; Jiang N; Zhang H; Wu XY
Cancer Lett; 2021 Feb; 499():85-98. PubMed ID: 33279623
[TBL] [Abstract] [Full Text] [Related]
18. Estrogen-induced epigenetic silencing of
Muhammad JS; Bajbouj K; Shafarin J; Hamad M
Epigenetics; 2020 Dec; 15(12):1302-1318. PubMed ID: 32476555
[TBL] [Abstract] [Full Text] [Related]
19. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells.
Bai T; Lei P; Zhou H; Liang R; Zhu R; Wang W; Zhou L; Sun Y
J Cell Mol Med; 2019 Nov; 23(11):7349-7359. PubMed ID: 31507082
[TBL] [Abstract] [Full Text] [Related]
20. Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
Adachi M; Kai K; Yamaji K; Ide T; Noshiro H; Kawaguchi A; Aishima S
Histopathology; 2019 Jul; 75(1):63-73. PubMed ID: 30811632
[TBL] [Abstract] [Full Text] [Related]
[Next]
